R
Overview
Radiologische Allianz eGbR provides specialized radiology and radiation therapy services in Europe for hospitals, clinics, and patients. It performs diagnostic imaging (including PET-CT) and therapeutic procedures (like IMRT) to diagnose and treat conditions. The company uses neuroradiology expertise and advanced planning technologies, such as direct aperture optimization and multimodality contouring, to plan and deliver precise treatments. Its goal is to improve patient outcomes through high-quality imaging and targeted radiation therapy, supported by academic partnerships.
Work here?Claim your company
Simplify's take
What believers are saying
- May 2026 brought a second PET/CT in Spitalerhof, expanding cancer-diagnostic capacity.
- April 2026 Uelzen preserved a sole local radiology site and added a second MRI.
- July 2026 Mörkenstraße received a new MRI, signaling ongoing capex and modernization.
What critics are saying
- Recruiting enough radiologists and MTRA staff for Uelzen and Ahrensburg strains 2026 growth.
- The three-million-euro PET/CT investment raises utilization pressure if oncology volumes soften in 2027.
- One technical outage at PET/CT Zentrum Hamburg would hit referrals, revenue, and reputation immediately.
What makes Radiologische Allianz eGbR unique
- Radiologische Allianz runs 26 North German sites, giving unmatched regional referral density.
- Its 2026 PET/CT expansion and Uelzen acquisition deepen specialty coverage across Hamburg.
- The group combines radiology, nuclear medicine, radiation therapy, and radiochirurgie under one roof.
Help us improve and share your feedback! Did you find this helpful?